388 related articles for article (PubMed ID: 10945805)
1. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
Pillon B; Gouider-Khouja N; Deweer B; Vidailhet M; Malapani C; Dubois B; Agid Y
J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):174-9. PubMed ID: 7876847
[TBL] [Abstract][Full Text] [Related]
3. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
4. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
Luca A; Nicoletti A; Donzuso G; Terravecchia C; Cicero CE; D'Agate C; Rascuná C; Manna R; Mostile G; Zappia M
J Alzheimers Dis; 2021; 80(4):1669-1674. PubMed ID: 33720901
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
6. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
7. [Axial (neck and trunk) rigidity in Parkinson's disease, striatonigral degeneration and progressive supranuclear palsy].
Nagumo K; Hirayama K
Rinsho Shinkeigaku; 1996 Oct; 36(10):1129-35. PubMed ID: 8997136
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of parkinsonian syndromes according to differences in executive functions.
Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
[TBL] [Abstract][Full Text] [Related]
9. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
[TBL] [Abstract][Full Text] [Related]
11. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
Krishnan S; Mathuranath PS; Sarma S; Kishore A
Neurol India; 2006 Sep; 54(3):268-72. PubMed ID: 16936386
[TBL] [Abstract][Full Text] [Related]
13. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
[TBL] [Abstract][Full Text] [Related]
15. Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease.
Wang L; Kuroiwa Y; Kamitani T; Li M; Takahashi T; Suzuki Y; Shimamura M; Hasegawa O
J Neurol; 2000 May; 247(5):356-63. PubMed ID: 10896267
[TBL] [Abstract][Full Text] [Related]
16. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
[TBL] [Abstract][Full Text] [Related]
17. Progressive supranuclear palsy: MRI and pathological findings.
Yagishita A; Oda M
Neuroradiology; 1996 May; 38 Suppl 1():S60-6. PubMed ID: 8811682
[TBL] [Abstract][Full Text] [Related]
18. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
Taniguchi D; Hatano T; Kamagata K; Okuzumi A; Oji Y; Mori A; Hori M; Aoki S; Hattori N
Mov Disord; 2018 Sep; 33(9):1488-1492. PubMed ID: 29756366
[TBL] [Abstract][Full Text] [Related]
19. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
20. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
Ondo W; Warrior D; Overby A; Calmes J; Hendersen N; Olson S; Jankovic J
Arch Neurol; 2000 Oct; 57(10):1464-9. PubMed ID: 11030799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
